Clinical Trials
AIVITA Biomedical completes patient enrollment target in phase 2 GBM trial for glioblastoma
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that it has reached its patient enrollment target in the company's...
Clinical Trials
Sanofis phase 2 study of BTK inhibitor, SAR442168 meets primary endpoint to treat MS
The Sanofi phase 2b study evaluating its investigational BTK (Brutons tyrosine kinase) inhibitor (SAR442168), an oral, brain-penetrant, selective small molecule, achieved its primary endpoint.
In...
Clinical Trials
Teva Announces Positive Top-Line Results from AJOVY Clinical Trials in Japan
Teva Pharmaceutical Industries Ltd announced positive results from two Phase 2/3 trials evaluating AJOVY® (fremanezumab) in patients in Japan. AJOVY is under development in...
Drug Research
Aimmune secures $200m funding from Nestle Health Science
Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that Nestlé Health Science will...
Press Releases
Assertio Therapeutics Announces Sale of NUCYNTA Franchise to Collegium Pharmaceutical for $375.0 Million
Assertio Therapeutics, Inc. announced it has entered into a definitive agreement with Collegium Pharmaceutical, Inc. pursuant to which Collegium will acquire the NUCYNTA franchise...
Clinical Trials
NeuroSense initiates clinical studies to evaluate benefit of PrimeC for ALS patients
NeuroSense Therapeutics, a biotech company developing PrimeC, a combination drug which aims to slow or halt ALS progression, announced the initiation of two clinical...
News
Interphex to feature strategies and solutions to maximize, innovative and accelerate
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical, biotechnology and device innovation, technology and knowledge from development through commercialization, and the Parenteral...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read